Integrated into the Clarius App, the new AI tool automates LVEF calculation—the key indicator of heart pumping efficiency—to ...

Q: Can you tell me about ejection fractions? My wife’s heart doctor recently told us that her heart is weak, and she has a low ejection fraction. He did not discuss this much, but he has put her on ...

BioCardia Inc. (NASDAQ:BCDA) shares surged 26.2% in premarket trading on Friday after the company announced that the U.S.

LONDON — The benefit of mineralocorticoid receptor antagonists (MRAs) for the treatment of patients with heart failure and mildly reduced or preserved ejection fraction has finally been established in ...

Background Heart failure with preserved ejection fraction (HFpEF) is characterised by systemic congestion and elevated left ...

BioCardia Inc. BCDA stock is up on Friday as the company is confirming progress toward potential market approval for its ...

Reclassifying HFmrEF as a stable phenotype aims to reduce therapeutic inertia and GDMT underuse driven by heterogeneous labeling and clinician uncertainty. Pathobiologic overlap with HFrEF supports ...

Heart disease affects women differently than men, and understanding those differences can be lifesaving. Dr. Sharonne N. Hayes, a Mayo Clinic cardiologist and leading expert in the field of women's ...

The role of ACE inhibitors in the management of HFPEF is less significant compared with their role in the management of heart failure with left ventricular systolic dysfunction. For patients with ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software. This software utilises AI to detect individuals with a low left ...